Please use this identifier to cite or link to this item: http://hdl.handle.net/20.500.12857/182978
Title: The hazard of (sub)therapeutic doses of anticoagulants in non-critically ill patients with Covid-19: The Padua province experience
Authors: Pesavento, Raffaele 
Ceccato, Davide
Pasquetto, Giampaolo 
Monticelli, Jacopo
Leone, Lucia
Frigo, Annachiara
Gorgi, Davide
Postal, Anna
Marchese, Giuseppe Maria
Cipriani, Alberto 
Saller, Alois
Sarais, Cristiano 
Criveller, Pietro
Gemelli, Marco
Capone, Federico
Fioretto, Paola 
Pagano, Claudio 
Rossato, Marco 
Avogaro, Angelo 
Simioni, Paolo 
Prandoni, Paolo
Vettor, Roberto 
Keywords: COVID-19;anticoagulants;bleeding;coronavirus 2019;venous thromboembolism
Keywords Plus: ANTITHROMBOTIC THERAPY;DISEASE;VTE
Issue Date: Oct-2020
Publisher: WILEY
Journal: Journal of thrombosis and haemostasis : JTH 
Abstract: 
Coronavirus Disease 2019 (COVID-19) is responsible for a worldwide pandemic, with a high rate of morbidity and mortality. The increasing evidence of an associated relevant prothrombotic coagulopathy has resulted in an increasing use of antithrombotic doses higher than usual in COVID-19 patients. Information on the benefit/risk ratio of this approach is still lacking.
URI: http://hdl.handle.net/20.500.12857/182978
ISSN: 15387933
DOI: 10.1111/jth.15022
Appears in Collections:Articles

Show full item record

PubMed Central
Citations

24
Last Week
0
Last month
4
checked on May 2, 2021

WEB OF SCIENCETM
Citations

40
checked on Nov 28, 2021

Page view(s) 5

2
checked on Nov 29, 2021

Google ScholarTM

Check

Altmetric


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.